Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cheifetz

Showing results (51-60 of 263) with videos related to

Pageof 27
Sort By:
Alimentary Pharmacology & Therapeutics|September 26, 2021
Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's diseaseShana Rakowsky, Adam S Cheifetz, Konstantinos Papamichael
Alimentary Pharmacology & Therapeutics|April 1, 2022
Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD?Shana Rakowsky, Adam S Cheifetz, Konstantinos Papamichael
The Journal of Biological Chemistry|November 15, 1988
The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptorS Cheifetz, J L Andres, J Massagué
Journal of Clinical Medicine|November 25, 2023
Drug Clearance in Patients with Inflammatory Bowel Disease Treated with BiologicsTina Deyhim, Adam S Cheifetz, Konstantinos Papamichael
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
ReplyKonstantinos Papamichael, Mark T Osterman, Adam S Cheifetz
JAMA|September 21, 2021
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory DiseasesKonstantinos Papamichael, Marla C Dubinsky, Adam S Cheifetz
Inflammatory Bowel Diseases|March 22, 2012
Varicella zoster virus infection in inflammatory bowel diseaseGarret Cullen, Rachel P Baden, Adam S Cheifetz
Current Treatment Options in Gastroenterology|January 8, 2014
The role of mucosal healing in the treatment of patients with inflammatory bowel diseaseByron P Vaughn, Sveta Shah, Adam S Cheifetz
Gastroenterology|April 18, 2022
Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's DiseaseKonstantinos Papamichael, Marla C Dubinsky, Adam S Cheifetz
The American Journal of Gastroenterology|January 8, 2011
Vaccination in inflammatory bowel diseaseGarret Cullen, Rachel P Baden, Adam S Cheifetz
Pageof 27

Showing results (51-60 of 263) with videos related to

Sort By:
Pageof 27
Alimentary Pharmacology & Therapeutics|September 26, 2021
Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's diseaseShana Rakowsky, Adam S Cheifetz, Konstantinos Papamichael
Alimentary Pharmacology & Therapeutics|April 1, 2022
Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD?Shana Rakowsky, Adam S Cheifetz, Konstantinos Papamichael
The Journal of Biological Chemistry|November 15, 1988
The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptorS Cheifetz, J L Andres, J Massagué
Journal of Clinical Medicine|November 25, 2023
Drug Clearance in Patients with Inflammatory Bowel Disease Treated with BiologicsTina Deyhim, Adam S Cheifetz, Konstantinos Papamichael
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
ReplyKonstantinos Papamichael, Mark T Osterman, Adam S Cheifetz
JAMA|September 21, 2021
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory DiseasesKonstantinos Papamichael, Marla C Dubinsky, Adam S Cheifetz
Inflammatory Bowel Diseases|March 22, 2012
Varicella zoster virus infection in inflammatory bowel diseaseGarret Cullen, Rachel P Baden, Adam S Cheifetz
Current Treatment Options in Gastroenterology|January 8, 2014
The role of mucosal healing in the treatment of patients with inflammatory bowel diseaseByron P Vaughn, Sveta Shah, Adam S Cheifetz
Gastroenterology|April 18, 2022
Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's DiseaseKonstantinos Papamichael, Marla C Dubinsky, Adam S Cheifetz
The American Journal of Gastroenterology|January 8, 2011
Vaccination in inflammatory bowel diseaseGarret Cullen, Rachel P Baden, Adam S Cheifetz
Pageof 27